Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase 1 3Phase 2/3 2Phase 1/2 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 170Neoplasm Metastasis 139Neoplasms 136Leukemia, Myeloid, Acute 133Colorectal Neoplasms 115Breast Neoplasms 115Melanoma 90Ovarian Neoplasms 88Prostatic Neoplasms 85Recurrence 83Multiple Myeloma 81Lung Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Pancreatic Neoplasms 70Myelodysplastic Syndromes 63Lymphoma, Non-Hodgkin 59Triple Negative Breast Neoplasms 53Glioma 53Stomach Neoplasms 49Endometrial Neoplasms 46Brain Neoplasms 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma, Large B-Cell, Diffuse 45Carcinoma, Renal Cell 45Small Cell Lung Carcinoma 44Lymphoma, Follicular 40Lymphoma, B-Cell 40Carcinoma, Hepatocellular 40Sarcoma 39

Interventions

Taxes 2Platinum 2Gemcitabine 2Cisplatin 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Gallbladder Neoplasms × 90 days × Clear all
NCT07594964 2026-05-19

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Shenzhen Xinhe Biomedical

Phase 1 Recruiting
48 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Cholangiocarcinoma

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
61 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT05285358 2026-03-13

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

City of Hope Medical Center

Phase 1 Recruiting
12 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡